eISSN: 2299-0054
ISSN: 1895-4588
Videosurgery and Other Miniinvasive Techniques
Current issue Archive Videoforum Manuscripts accepted About the journal Supplements Editorial board Journal's reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank

 
Share:
Share:
more
 
 
abstract:
Review paper

Robotic adrenalectomy versus laparoscopic adrenalectomy for pheochromocytoma: a systematic review and meta-analysis

Lei Du
1
,
Zhan Yang
1
,
Jinchun Qi
1
,
Yaxuan Wang
1

1.
Department of Urology, The Second Hospital of Hebei Medical University, Shijiazhuang, China
Videosurgery Miniinv
Online publish date: 2021/07/13
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
The application of robotic adrenalectomy (RA) has been increasing. However, there is still controversy about whether RA is more feasible than laparoscopic adrenalectomy (LA) for pheochromocytoma (PHEO).

Aim
To evaluate the efficacy and safety of RA vs. LA for PHEO.

Material and methods
A literature search of the PubMed, Ovid, and Scopus databases was performed to identify eligible studies up to April 2021. All studies comparing RA versus LA for PHEO were included. Data were analysed using the Cochrane Collaboration’s Review Manager (RevMan) 5.4 software.

Results
Overall, 4 studies including 386 patients (RA 155; LA 231) were included. RA might have larger tumour size (WMD = 0.72 cm, 95% CI: 0.31 to 1.13; p < 0.001). There were no statistically significant differences in operative time (WMD = –12.49 min, 95% CI: –29.50 to 4.52; p = 0.15), estimated blood loss (EBL) (WMD = –28.48 ml, 95% CI: –58.92, 1.95; p = 0.07), transfusion rate (OR = 0.70, 95% CI: 0.07 to 7.07; p = 0.77), or conversion rate (OR = 0.44, 95% CI: 0.07 to 2.88; p = 0.39). There were no significant differences between the 2 groups in terms of postoperative complications (OR = 1.06, 95% CI: 0.62 to 1.82; p = 0.84) and Clavien Dindo score ≥ 3 complications (OR = 1.15, 95% CI: 0.39 to 3.41; p = 0.80). Patients from the RA group could benefit from shorter length of hospital stay (WMD = –0.51 days, 95% CI –0.91 to –0.12; p = 0.01).

Conclusions
RA is a feasible, safe, and comparable treatment option for PHEO.

keywords:

robotic adrenalectomy, laparoscopic adrenalectomy, pheochromocytoma, meta-analysis

  
Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe